| 2.15 0.01 (0.47%) | 04-14 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.56 | 1-year : | 3 |
| Resists | First : | 2.19 | Second : | 2.56 |
| Pivot price | 2.1 |
|||
| Supports | First : | 2.08 | Second : | 2 |
| MAs | MA(5) : | 2.14 |
MA(20) : | 2.08 |
| MA(100) : | 2.1  |
MA(250) : | 2.09 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 66.8 |
D(3) : | 67.3 |
| RSI | RSI(14): 66.5 |
|||
| 52-week | High : | 2.71 | Low : | 1.63 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ FORA ] has closed below upper band by 20.5%. Bollinger Bands are 90% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.15 - 2.16 | 2.16 - 2.17 |
| Low: | 2.11 - 2.13 | 2.13 - 2.14 |
| Close: | 2.13 - 2.15 | 2.15 - 2.17 |
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
Sun, 12 Apr 2026
FORA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Wed, 08 Apr 2026
Forian Inc. (FORA) faces planned cash tender offer under April 2, 2026 merger - Stock Titan
Mon, 06 Apr 2026
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Forian Inc. (NASDAQ: FORA) - PR Newswire
Mon, 06 Apr 2026
FORA Stock Alert: Halper Sadeh LLC is Investigating Whether Forian Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
Sat, 04 Apr 2026
Forian to Go Private in CEO-Led Takeover Deal - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 31 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 49.1 (%) |
| Held by Institutions | 13 (%) |
| Shares Short | 60 (K) |
| Shares Short P.Month | 75 (K) |
| EPS | -0.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1 |
| Profit Margin | -3.1 % |
| Operating Margin | -6.1 % |
| Return on Assets (ttm) | -4.8 % |
| Return on Equity (ttm) | -3 % |
| Qtrly Rev. Growth | 65.5 % |
| Gross Profit (p.s.) | 0.5 |
| Sales Per Share | 0.9 |
| EBITDA (p.s.) | -0.12 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -107.51 |
| PEG Ratio | 0 |
| Price to Book value | 2.15 |
| Price to Sales | 2.37 |
| Price to Cash Flow | 47.37 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|